Leveraging AI: Design. Automate. Degrade.
We design novel protein degraders to tackle challenging targets in oncology with our proprietary platform joining ML-enabled models and a high throughput experimentation process (Direct-to-Biology) for scalable and fast development of protein degraders.
CelerisTx develops proprietary assets and collaborates with pharmaceutical and biotech companies.
Leveraging AI:
Design. Automate. Degrade.
We are CelerisTx
We are an international team of highly skilled experts from disciplines as computational chemistry, medicinal chemistry, biology and machine learning.
Our team is complemented by highly esteemed advisors and investors at the intersection of artificial intelligence and life sciences.
One Team. One Vision.